In addition, mTOR, PI3K/AKT, and AMPK signaling are closely associated with glycolysis in gliomas [18].Overall, glycolysis is intricately linked to the activity of glioma cells; therefore, it is a promising target for novel glioma treatment approaches. The gene discussed is AKT1; the disease is central nervous system cancer.